Dermatologists recognize three main types of reaction of the skin to tests with allergens: (I) Whealing; (2) Papular; (3) Eczematous. The two last are both delayed reactions, but one, the papular or tuberculin type, is dermal, whereas the other, the eczematous, is epidermal. Even though the basic mechanism of these two allergic reactions may be closely related or identical, and though they may co-exist, it is important to remember that they can occur quite separately, and wrong conclusions can be drawn by failing to discriminate between them. As far as possible one ought to avoid speaking of sensitization of the skin and refer specifically to sensitization of the epidermis, dermis, or of the whole skin. I am going to devote my remarks to the third type.
in the same dose and concentration. The formation of complex-antigens may be considered proved in several instances, and highly probable in others, though many allergens cannot be shown to have any affinity for proteins.
Eczematous sensitivity is more highly specific than urticarial, and a further difference is that repeated applications of the allergen do not lead to a fall in reactivity, but rather the reverse.
An important antigen can be derived from skin itself. Since Whitfield's work (1921) , it has been widely recognized that in an eczematous patient the epidermis can become sensitized to contact with the exudate from a damaged area. Much clinical experience suggests that secondary and recurrent patches of eczema are caused by general sensitization to absorbed skin antigen. This is difficult to prove. We know, of course, from surgical experience in grafting that homogenous epidermis always acts as antigen.
Mechanism ofsensitization.-Hitherto the most reliable experimental method has been the primary application of the substance to the skin itself, perhaps because it there acts on tissue proteins for a longer period and at a higher concentration than if introduced elsewhere. But many experiments have shown that hypersensitiveness limited to the skin can be produced by primary injection into some other part of the body. Thus Landsteiner and Chase in 1939 showed that intraperitoneal injection of picryl chloride, mixed with a suspension of killed tubercle bacilli, induced hypersensitiveness to picryl chloride limited to the skin (epidermis).
Even when the primary application is made to the skin, does the process of sensitization take place in situ? To answer this, Landsteiner and Chase (1940) made skin islands about 35 mm. in diameter in guinea-pigs by excising a ring of skin around them. In some, the incisions were relatively superficial; in others they were deep enough to include the panniculus carnosus. When poison ivy extract was painted on to an island, if the moat was superficial, hypersensitiveness appeared on the island and outside it as well; if the moat was deep, no hypersensitiveness developed at all, even on the island. If the extract was painted on the skin outside a deeply moated island, hypersensitiveness developed both outside and on the island. These findings indicate that the antibody production does not take place locally in the skin, but centrally, and that the antibodies are transported to the skin by the bloodstream. Presumably the absorption of enough complex antigen depends on intact lymphatics and on the exposure of an adequate amount of tissue to the allergen. Seeberg (1951) sensitized guinea-pigs by one exposure to dinitrochlorbenzene by the following routes: epidermal, intracutaneous, subcutaneous and into an inguinal lymph gland. The subcutaneous route was less successful than the other three, but the lymph-gland route was equally successful with the epidermal and the intracutaneous routes.
If antibody production is central, there are some difficulties with regard to localization of sensitivity. In most cases of allergic eczema, it is true, all areas of the skin react positively to patch-tests, though in varying degrees. In some cases, however, a positive patch test is found only in or near the eczematous eruption. Haxthausen (1949) seeks to explain this by the existence of greater "unspecific lability" of eczematous skin and adjacent areas. In human subjects sensitized with dinitrochlorbenzene, he found that generally the positive reaction appeared first in the area of primary application. This, too, he attributed to unspecific lability set up by the irritant action of the primary application. After a few days all other parts of the skin reacted, and it was not possible to demonstrate any gradual spreading from the primary area to distant regions. But in the following case observed by me, such spreading from the primary area did seem to happen (Cavendish, 1940) . It was an instance of primary sensitization and spontaneous flare-up in situ:
A chemistry research worker presented himself with an unusual, severe, dusky-red, bullous eruption. Patch tests with suspected chemicals were negative except for 9-bromo-fluorene, which gave a mild reaction. As this might have been a simple irritant effect, it was tested on three controls, none of whom was likely to have come in contact with it before. The patch tests consisted of laying a small spot of the powder on the surface of the skin for twenty-four hours, and then cleaning it off. In the first control, nothing happened at all. In the second control, after eight days, a few temporary blisters occurred at the site of the patch test. The third control was more exciting. When the patch test was removed after twenty-four hours, there was only faint erythema, which quickly vanished. After thirteen days, at the site of the patch test, redness and blisters developed and spread contiguously over a wide area in a form closely imitating that of the original patient. Now, if the antibodies are formed centrally, why does the flare-up occur at the site of the patch test? Non-specific lability seems a strained explanation. Why in that case did it not begin with preference where the plaster was ripped off? Possibly the explanation in this case is the simple one that there was still a greater concentration of allergen there than at any other part of the skin. But why the extension by contiguity? You may feel that it is quite natural for inflammation to spread. But is it? A positive reaction to a patch test or an allergic reaction to the application of a piece of Elastoplast, for instance, or the non-allergic patch of inflammation produced by a Kromayer lamp, generally remains sharply limited to the original area of application. Moreover, the eruption in this control was not banal, but resembled that of the original case. If antibody production in the skin itself can occur, then the following hypothesis is suggested:
The portion of test substance absorbed into the skin during the twenty-four hours of application diffused outward during the subsequent latent period, initiating the sensitizing process in widening zones, one after the other. When the necessary thirteen days were up, the site of application reacted, and then successive zones followed suit at the same rate as the antigen had originally diffused, each by the same mechanism and after the same respective latent period.
If, on the other hand, antibodies are only produced centrally and circulated to t'le skin, then, after the latent period, any flare-up should take place simultaneously wherever therc is any antigen. In any case, we do not understand the sudden change from latency to explosion.
The Shwartzman phenomenon is also strongly in favour of the skin being itself the site of the sensitization process. Here the localization cannot possibly be due to there being more allergen at the original site, because the reaction is evoked by intravenous injection of fresh allergen.
If the process of sensitization is a local one, it should not depend on the extent of skin treated primarily by the antigen, but only on its concentration. Indeed Miescher (1941) , by painting guinea-pigs with different strengths of alcoholic solution of dinitrochlorbenzene, did show that higher concentrations sensitized more successfully, even though acting on smaller areas. But Haxthausen (1949) reduced this to an extreme by pricking the skin with a pin dipped in melted dinitrochlorbenzene. This caused a tiny red papule, but never any local or universal hypersensitiveness. He considered this an argument against a local mechanism. But here I feel that the amount coming in contact with epidermal cells would be subliminal.
Perhaps we are justified in concluding that both local and central mechanisms exist.
Even endogenous antigens (drugs) can sensitize epidermis in sharply demarcated patches. Passive transmnission.-Most attempts by modification of the Prausnitz-Kuistner technique have been negative, whether serum has been used or blister fluid: and some of the positive reports are open to criticism because the reaction elicited was urticarial. But UJrbach (1944) injected intracutaneously into a test subject the contents of a blister from a case of primula eczema, and over this site subsequently applied a primula leaf. This evoked a typical eczematous reaction.
To demonstrate the existence of circulating eczematous antibodies, Haxthausen (1943) made use of the fact that successful skin grafts can be made from one uniovular twin to the other. UJsing two pairs of twins, he sensitized one of each pair by epidermal application of dinitrochlorbenzene. When sensitization had been established, a piece of untreated skin from the sensitized twin was transplanted to the non-sensitized twin, and vice versa. The grafts healed well. Three weeks after the transplantation, epidermal tests revealed that the sensitive transplant had lost its sensitiveness in the normal environment, and that the normal transplant had acquired sensitiveness in the sensitized environment. This indicates that the state of eczematous hypersensitiveness is due to the presence of circulating, or at any rate diffusible antibodies. That they do circulate was further clinched by sensitizing guinea-pigs to dinitrochlorbenzene and then uniting them with untreated animals by parabiosis. In most cases, after a few days, the non-sensitized animals gave a positive epidermal reaction.
Whereas sensitiveness cannot be transferred by means of serum, it has been transmitted by lymphocytes. This was first shown rather inconclusively in 1942 by Landsteiner and Chase with picryl chloride. In 1947, Haxthausen transmitted sensitiveness to dinitrochlorbenzene and to Dixanthogen by intraperitoneal injection of lymphocytes from the thymus of sensitized animals, but it is important to note that if he injected lymphocytes intracutaneously he was unable to transfer sensitivity either from sensitized animals or from human cases of allergic eczema from various causes. This brings us to a wide gap in our knowledge, namely how do the lymphocytes transfer the antibodies to the avascular epidermis? One would think that it could only be through the medium of the plasma, for it is most improbable that there is any invasion of the epidermis by lymphocytes during the symptomless period of sensitization. One only sees such invasion in severe inflammations or lymphomas, and their presence in the epidermis is certainly not required for the reaction itself, as Nageli's experiments have clearly shown. It has been suggested that if the antibody has strong affinity for the cells of the skin, and is produced slowly in limited amount, the concentration in the blood would remain low. But Haxthausen's transplant experiment showed that the antibody to dinitrochlorbenzene at any rate was not very firmly held by epidermal cells (here, however, there is a little discrepancy with Niigeli's autotransplants in phenazone fixed eruption, which did indicate considerable fixity of antibodies to certain epidermal cells). The absence of antibodies from the serum, as well as the long latent period of the test reaction, have been attributed to the antibodies being located deeply in the cells (in contrast to those of urticaria, which seem to be regarded as standing recklessly on deck and being washed overboard into the blood stream). But located deeply in which cells? We have just seen that they may retain no firm anchorage to epidermal cells when transplanted, and if they are stowed deep in the hold of the lymphocytes it is still more difficult to understand how they are trans-shipped to the epidermal cells: and why does not fresh allergen, especially if introduced internally, disrupt the lymphocytes? Are the antibodies present there only in some precursor form?
Dinitrochlorbenzene sensitiveness in female guinea-pigs is not transmitted to the offspring, so probably the antibody is a high molecular protein.
The ultimate mechanism, i.e. the consequence of the allergen-antibody encounter.-Histamine cannot reproduce the eczematous type of reaction. Neither in eczema caused by chemicals nor in that produced by sensitization to ultraviolet rays can histamine-release be shown to be instrumental, and antihistaminic drugs, as such, neither prevent nor cure it. Possibly the ultimate mechanism is of the kind worked out by Peters (1945) , in which there is release of a tissue protease. But leucotaxis, if it occurs, is only a secondary phenomenon. The reaction itself is seen histologically as an oedema in and between the prickle-cells, which burst. Both Rich and Nageli have shown clearly that this is independent of the presence of blood vessels or extraneous inflammatory cells.
Are the clinical differences between the characteristic effects of certain allergens referable entirely to the selection of cells by antibodies, or may it be that the ultimate mechanism does differ to some extent with different allergen-antibody encounters?
ACTH and cortisone.-In contrast to antihistaminic drugs, cortisone is more inhibitive in the delayed than in the immediate type of allergic reaction, and in epidermal more than in dermal responses. Cruickshank (1952) has found that there is slight inhibition of reactions to patch tests. Topical application to the skin is ineffective. past, methods for studying histamine release from tissues have been limited because we had few means by which we could produce an effective release without damaging the tissue. The position has changed, particularly through the work of MacIntosh and Paton (1949) , and we have now at our disposal a variety of substances, some simple amines, some chemically more complicated substances, which when injected into an animal or into the artery of a perfused organ release histamine without producing visible tissue damage: the so-called histamine liberators. The one used in the present experiments is compound 48/80, a condensation product of p-methoxyphenethyl-methylamine. Paton and I (1951) perfused a flap ofcat's skin with Tyrode's solution from the artery (the saphenous) and then injected a few pg. of 48/80 into the artery, with the result that histamine appeared in the venous effluent. Fig. 1 illustrates this release of histamine from a perfused skin flap by an arterial injection of 10 pig. compound 48/80. When 48/80 is injected into the whole animal, the histamine released in the skin causes increased permeability of the skin capillaries at the site of its liberation, and if the consequent fluid exudation is sufficient, cedema results. If not, the increased capillary permeability can still be detected by injection of a colloidal dye. Miles and Miles (1952) used pontamine sky blue for this purpose. Skin areas in which the permeability of the capillaries is increased become quickly blue. Miles and I (1953) injected 48/80 intravenously into guinea-pigs with circulating pontamine blue. The skin did not blue at once all over the body. Blueing started, and became intense within a few minutes, in the eyelids, around the mouth, at the base of the ear, in the submental region; during the following minutes the blueing spread all over the head and neck region and was intense around the areolar area of the nipples. This is illustrated in Fig. 2 . There was also some deep blueing in the perineum; but the trunk and hind legs were only faintly stained and the staining was often patchy.
If the degree of blueing is, as we assume, dependent on the state of permeability of the capillaries, then these findings would represent a regional pattern of increased permeability of the skin capillaries after 48/80; and the question arises what is the cause? Miles and I determined the histamine content in various skin regions and found that the regional pattern of blueing was, with one exception (the distal parts of the legs), directly related to the histamine content of the skin. The regional variations of histamine content of the skin of the guinea-pig are seen from Fig. 3 . Miles has recently shown that in guinea-pigs sensitized 33 6 ,'2 2 with various antigens, the simultaneous injection of antigen 7< i\ ' f \ Sand pontamine sky blue produces blueing which extends '-4 to the feet as well, so that in this allergic phenomenon the 22uit 4.. 24S1 agreement between skin histamine content and increased capillary permeability is even better than after 48/80. \ , / Similar regional pattern s concerning histamine content ' ' and proneness to increased permeability of the skin capill li laes were found to exist in other species. For instance, . l l Paton and Schachter (1951) Miles, J. Physiol., 1953.) creasedcapillary permeability, other factors must not be forgotten. For instance, the mechanical factor; the looseness of a tissue will determine the degree of oedema in those areas in which increased permeability occurs.
One further point must be mentioned. Apart from regional differences in skin histamine, there are great species differences in the histamine content of the skin. The meaning of these differences is not clear, but as far as the evidence is available, the regional differences seem to occur, at least to a certain extent, whether the general level of skin histamine of a species is high or low. The question naturally arises whether similar regional differences in skin histamine exist in the human, and, if so, whether they can be related to regional differences of allergic and other dermatological manifestations.
To return to the experiments on rats. Talesnik and I(1953) succeeded in greatly reducing and practically depleting the histamine in the skin and skeletal muscle of rats by repeated intraperitoneal injections of 48/80 in increasing dosage. A dose of 48/80 which on first injection causes severe cedema of the characteristic distribution becomes ineffective after several injections; but at this stage the rats respond again to larger doses of 48/80 until they become also ineffective on repeated injections. When the rats are then killed, the skin and muscle histamine is found to be low. This is illustrated in Fig. A. N. Smith and I tried to repeat these findings in guinea-pigs and mice, but succeeded in reducing skin histamine to a relatively small extent only; in cats, Smith (1953) was able, however, to reduce the skin histamine by 48/80 as much as in rats. Once the skin histamine is "depleted" it takes long time until it is restored (Fig. 3 ). This finding gave us the opportunity to study in rats with very low histamine content of the skin, skin reactions closely related to allergic phenomena.
Rats are hypersensitive to egg white, as shown by Selye (1937) . That is, its first intraperitoneal injection in the non-sensitized animal leads to cedema in the face and paws; in fact the distribution of the cedema is the same as that seen after 48/80. We were interested in this oedema, because of the question whether it was an effect of histamine released by the egg white in the skin and acting locally at the site of its liberation. The answer to this question would be simple if intravenous injections histamine would reproduce the effect, but they do not. On the other hand, the cedema is prevented antihistamine drugs and, further, Schachter and Talesnik (1952) were able to show that, injected into rats, egg white released histamine. The question then was: what would be the effect of egg white rats in which the skin histamine had been greatly reduced or practically depleted? Talesnik and I found that in such rats egg white no longer produced cedema. The rats had, so to speak, become resistant to egg white because there was no longer sufficient histamine available in the skin to be released it and to cause the increased capillary permeability at the site of release.
When these results were communicated to the Physiological Society, Sir Henry Dale suggested that Talesnik and I also test the effect of light in photosensitized rats after treatment with 48/80. Professor C. Rimington kindly provided us with some purified hematoporphyrin. When normal rats were exposed to the light from a carbon lamp, twenty hours after an intraperitoneal injection of heematoporphyrin, they became restless, started to scratch violently and then one group of rats became listless and weak and was sitting in the cage with ruffled fur and intense cyanosis; some rats died.
The other group of rats developed aedema in the face, head, ears and in the paws.
On the other hand, rats treated first with 48/80 and then injected with hematoporphyrin showed a definite resistance to light. Apart from some scratching during the exposure to light, some of these rats showed no further signs; the other rats became slightly swollen in the ears but all other effects seen in the control rats were absent and none died. So at least two kinds of skin phenomena closely related to allergic reactions can be more or less prevented in rats in which the skin histamine has been greatly reduced.
In the cedema produced in rats by 48/80, egg white or light, we encounter a phenomenon which is due to histamine but which cannot be reproduced by intravenous histamine injections, because they do not imitate the local effect of histamine at the site of its release.
On the other hand, a histamine-like effect does not need to be due to histamine. An allergic contraction of a smooth muscle, although reproducible by histamine, can well be the result of another pharmacologically active substance released by the antigen-antibody reaction or the "allergen". Recently, Humphrey and Jaques (1952) reported that the antigen-antibody reaction releases from the rabbit's platelets not only histamine but another pharmacologically potent smooth-muscle-contracting 70 r 601- The Prausnitz-Ktlstner reaction shows that the serum of allergic subjects contains a substance that reacts specifically with the corresponding allergen; This substance, called a reagin, behaves therefore as an antibody, but it has certain peculiarities. The reagin seems to be distinct from the ordinary precipitable antibody; in most cases the serum of allergic patients does not form a precipitate with the corresponding allergen. Sensitizing substances comparable to reagin may appear in the serum of normal persons after injections of horse serum, but the amount of reagin, as measured by the minimum amount that will give a P.K. reaction, does not run parallel to the amount of precipitable antibody (Tuft and Ramsdell, 1929) .
Of recent years the investigations on erythroblastosis fetalis have drawn attention to incomplete antibodies and there is a tendency to imagine that "incompleteness" may account for any peculiarities of antibodies. An antibody is said to be incomplete when it will not form a precipitate with, or agglutinate, the corresponding antigen. I deprecate the use of the term "univalent"; for, though there is now good evidence that the precipitating antibodies are bivalent, there is no evidence that incomplete antibodies are univalent.
The concept of incomplete antibodies started in 1935 when Heidelberger and Kendall found.that when 7-6 mg. of the antigen, ovalbumin, were added, in one instalment, to 5 ml. rabbit antiserum, 91 mg. of antibody protein were precipitated from the antiserum and they also found that no antigen or antibody could be detected in the supernatant fluid. If, however, ovalbumin was added in small instalments, until no further precipitate formed, only 71 mg. of protein were precipitated. Heidelberger and Kendall inferred that the 5 ml. of antiserum contained 91-71 = 20 mg. of antibody that would not, by itself, form a precipitate with antigen, but would combine with vacant sites on antigen molecules precipitated by ordinary antibody molecules. When small instalments of antigen were added they combined preferentially with the precipitable (complete) antibody. They found that this 20 mg. left unprecipitated was carried down with the precipitate formed by a further lot of antiserum to which a suitable amount of ovalbumin was added i' one instalment.
There is no reason to suppose that the formation of incomplete antibodies is an abnormal occurrence. Most of the antibody formed by dogs in response to injections of a protein such as ovalbumin is incomplete and rabbits form varying amounts of incomplete antibodies. It is difficult to decide whether the skin-sensitizing antibody formed, for example, by a rabbit immunized with ovalbumin is actually contained in the incomplete fraction as Sherman et al. (1950) have claimed. In response to injections of ovalbumin rabbits may form considerable amounts of antibodies to other proteins, which are contained as impurities in the sample of ovalbumin used (Munoz and Becker, 1950) . When the greater part or all of the antibody against ovalbumin has been precipitated, these other antibodies are left in the supernatant fluid; if the allergen is one of these impurities the amount of the serum required to sensitize the skin passively will be unaffected. Sherman et al. (1950) did not exclude this possibility; and Orlans (1952, unpublished) found that the serum of an egg-sensitive patient formed a precipitate with an impurity of ovalbumin. Similarly, Bukantz et al. (1949) found evidence of an incomplete antibody in the serum of patients who had had a course of injections of ragweed pollen extract; this suggests that the blocking antibody was also an incomplete antibody. But the incomplete antibody detected may well have not been antibody against the allergen, but against some other constituent of the pollen extract. Becker and Munoz (1949) have shown by Oudin's (1947) method that antisera against ragweed pollen contain antibodies against several antigens.
Unless the allergen is isolated in a fairly pure state it is difficult to decide whether any antibody, complete or incomplete, is actually antibody against the actual allergen. Orlans, Rubinstein and Marrack (1953) demonstrated by Boyden's (1951) method antibodies in the serum of hay-fever patients who had been treated with injections of pollen extract. But we could not infer that these were the blocking antibodies.
The reagins may well be incomplete antibodies, but incompleteness is not the feature that distinguishes them from other antibodies. One feature that appears abnormal is that they become firmly attached where they are injected and may remain for several days, whereas other antibodies, including the blocking antibodies, diffuse away. A peculiarity of allergic persons is not so much that they form capillary fragility whenever the drug is taken by a sensitized individual. These changes result in extensive hxemorrhages throughout the body.
The usual clinical story is that the drug has-been taken over a period of days, weeks, or sometimes even years, with no untoward resjlt and then suddenly, following a single dose, an attack of purpura has ensued. If no further Sedormid is taken recovery is rapid and is usually complete within a week. The hypersensitivity, once it has been established, persists for a long time. It is not known whether it can ever disappear entirely. The diagnosis can be confirmed only by showing that the administration of a test dose of the drug, after recovery, gives rise to a further attack of purpura.
Action of Sedormid on the platelets.-Studies of blood clotting in the presence of Sedormid have shown that Sedormid greatly reduces clot retraction in the blood of sensitized individuals (Ackroyd, 1949a) . This is due to lysis of platelets by Sedormid during coagulation (Ackroyd, 1949b) .
Sedormid also causes agglutination and lysis of platelets when added to the fluid blood of sensitized patients (Ackroyd, 1949c) . The lysis of platelets by Sedormid in the heparinized plasma of a sensitized patient is shown in Fig. 1 Allergy, 1952, 3, 552) Platelet lysis by Sedormid involves the fixatidn of complement (Ackroyd, 1951) .
Sedormid has no action on the blood of controls. If platelets isolated from normal blood are suspended in normal sera and in the sera of Sedormidsensitive patients, and the platelets of such patients:'ate suspended in normal sera and in the sera of Sedormid-sensitive patients, and the action of Sedormid on the resulting mixtures is observed, it will be found that Sedormid causes platelet lysis and complement fixation only in preparations containing serum from Sedormid-sensitive patients. In other words, Sedormid causes lysis of both normal platelets and those of Sedormid-sensitive patients when these are suspended in serum from sensitized patients, but the platelets of sensitized patients are not lysed by Sedormid in normal sera. These findings are shown schematically in Fig. 2 . They show conclusively that the abnormality in the blood of patients who have recovered from Sedormid purpura lies in the serum and not in the platelets (Ackroyd, 1951) . The complement-fixation reaction has been used to analyse the action of Sedormid, and it has been shown that:
(1) Platelets are essential for complement fixation by Sedormid.
(2) Red and white cells cannot replace platelets in this reaction.
(3) Heating the sera of sensitized patients at 560 C. for half an hour inactivates the complement but does not destroy the lytic factor. This can be demonstrated in the heated sera after the addition of further complement.
(4) In the absence of complement, Sedormid causes agglutination of platelets, but does not cause platelet lysis. Action ofSedormid on the capillaries.-The application of Sedormid to the skin of sensitized patients causes the appearance of petechial hemorrhages in the area of skin to which the patch is applied (Ackroyd, 1949a) . The affected area shows neither hypereemia nor wheal formation; which suggests that the hemorrhages are not due to the release of histamine. The skin over the rest of the body is normal and the platelet count is unaltered. Sedormid has no effect on the skin of controls. The appearance of the skin of a sensitized patient after the application of Sedormid for forty-eight hours is shown in Fig. 3 .
These investigations show that Sedormid causes platelet lysis in the blood of sensitized patients. This is presumably the cause of the thrombocytopenia in Sedormid purpura. Sedormid also causes hemorrhages in the skin of such individuals. These appear to be independent phenomena, for platelet lysis occurs in vitro, and the capillary haemorrhages produced by patch testing occur in the absence of thrombocytopenia.
The observations on platelet lysis show that four factors are concerned; platelets, Sedormid, complement, and the serum of a sensitized patient. Platelet lysis does not occur in the absence of any one of these factors, although platelet agglutination occurs in the absence of complement. No other immune lytic reaction appears to have been described in which more than three participating factors are involved, namely; antigen, antibody and complement. In the lysis of platelets by Sedormid, it seems probable that the antibody is in the patient's serum. If this is so, then it suggests that a union of Sedormid with platelets may constitute the antigen, this antigen undergoing lysis in the presence of antibody and complement. This concept readily explains the agglutination of platelets, without lysis by Sedormid in the absence of complement, for in all immunological reactions characterized by agglutination and lysis, agglutination of the antigen occurs in the absence of complement, although complement is necessary for lysis. Scd., 1949, 7, 285.) As Sedormid causes, in vitro, lysis of the platelets of normal individuals, it would seem that this Sedormid-platelet antigen must be formed whenever Sedormid comes into contact with platelets and, therefore, that it is present in the blood stream in all patients taking the drug. That only a minute proportion of these develops purpura can best be explained on the supposition that the union of Sedormid with platelets results in a compound of extremely low antigenicity, and that only those patients whose immunity reactions are stimulated by this antigen will manufacture the antibody, and so develop thrombocytopenia.
It is clear, therefore, that patients who have recovered from Sedormid purpura probably have, in their blood stream, an anti-platelet antibody which can cause lysis of platelets rendered antigenic by union with Sedormid. Now Bedson (1922) has shown in animals that anti-platelet serum not only causes platelet lysis, but also damages the vascular endothelium. It seems reasonable, therefore, to suppose that the capillary damage in Sedormid purpura is due to the action of the antibody which causes platelet lysis, and it may tentatively be suggested that Sedormid may combine with the endothelial cells to form a further antigen which then reacts with this antibody, so causing the vascular lesion which plays such an important part in the development of purpura. doses of cortisone and ACTH aiffect inflammatory processes generally, or only those with special causal mechanisms or types of tissue response. For this purpose we have compared the development of a variety of experimentally induced inflammations in the skin of patients before, during and after cortisone and ACTH administration. Treatment has usually been given for two weeks, cortisone 200 mg. daily and ACTH 150 mg. daily. I shall describe briefly our findings with lesions evoked by (1) tuberculin (P.P.D.), (2) manganese butyrate, which when injected intradermally, causes lesions with the same gross appearance as does tuberculin, but whose causal mechanism does not involve hypersensitivity, (3) atropine in sensitive subjects, (4) histamine, morphine and, in sensitive subjects, grass pollen and cat scurf.
(1) Tuberculin.-Using repeated tests with single dilutions of P.P.D. and variable doses of cortisone and ACTH, we were unable to satisfy ourselves that there was any consistent change attributable to treatment; the lesion sizes varied greatly even in control periods. This seems to have been the experience of others using similar methods. Experiments then showed that in man-as Wadley (1949) and Long and Miles (1950) have shown in animals-there is an approximately linear relationship between the lesion diameter and the logarithm of the dose of P.P.D. injected. Our method consisted in making 3-4 series of injections of several dilutions of P.P.D. in each patient in fortnightly periods before, during and after treatment. The mean regression lines were calculated from this data for each period and their positions were compared. The details of this method are described elsewhere (Lovell et al., 1953) .
Using this serial dilution method of testing and the relatively large doses of cortisone and ACTH, we found the reaction to P.P.D. was diminished in the 8 patients tested; the diminution was statistically highly significant in every case but one. The reactions sometimes remained diminished until a month after stopping treatment. As Long and Miles (1950) indicated in their guinea-pig studies, with data of this sort it is possible to express numerically the factor by which reactivity to P.P.D. is altered during treatment. In our cases, the factor by which reactivity was reduced was very variable, ranging from 15 to 170.
(2) Manganese butyrate.-As with P.P.D., we found that the diameter of the lesions bore an approximately linear relationship to the logarithm of the dose injected, and the reactions were studied by the same method I have described for P.P.D. The reactions were reduced by cortisone or ACTH in all the 9 patients tested. The changes were smaller than those with P.P.D. responses and did not attain statistical significance in 4 cases. The factors by which reactivity was reduced were remarkably consistent, being about two.
(3) Atropine.-In 2 sensitive subjects, repeated patch tests and instillation of eye-drops during cortisone treatment caused no inflammatory reactions, though these measures evoked reactions before and after treatment.
(4) Histamine, morphine, pollen and cat scurf.-In studying the triple responses evoked by these substances, we made use of the approximately linear relationship between wheal diameter and the logarithm of the concentration which Squire (1950) showed to exist, when pricks were made through histamine and horse dandruff solutions placed on the skin. We found no effect on these lesions with cortisone or ACTH.
The effects of an antihistamine substance provide a contrast with those of cortisone. We found that while promezathine reduces the size of histamine wheals, it does not influence the size of P.P.D. or manganese butyrate responses. From these studies we conclude:
(a) That the mechanisms involved in the development of the triple response, which include the release and effects of histamine, are refractory to the action of cortisone and ACTH; this is true whether or not a hypersensitivity reaction initiates the triple response.
(b) Cortisone and ACTH diminish reactivity to a direct irritant, manganese butyrate, only slightly. The approximately twofold reduction in reactivity is of an order comparable to that described by Jiirvinen (1951) for the reduced reactivity to ultraviolet light which is caused by cortisone.
(c) In sensitive subjects, reactivity to injected P.P.D. and to atropine ointment and eye-drops is diminished conspicuously.
It seems therefore that, in man, the chain of events comprising delayed inflammations-the sort evoked by manganese butyrate and P.P.D. as opposed to the triple responses-contains a link which is vulnerable to the effects of cortisone and ACTH. We do not know what this vulnerable link is.
One concept of this delayed sort of inflammation may be stated simply, and perhaps wrongly, thus: tissues are injured directly in the case of manganese butyrate and ultraviolet light, and as the result of a hypersensitivity mechanism in the case of tuberculin and atropine. As a result of this injury, diffusible chemical substances are liberated which evoke the tissue changes we recognize as inflammation, namely dilatation and increased permeability of blood vessels and cellular aggregations.
Cortisone might interrupt this process at any point. The fact that delayed inflammations due to direct damaging agents and to hypersensitivity mechanisms are both diminished might be held to favour the suggestion that cortisone acts at some stage beyond the causal process itself; for instance it might modify either the release of leucotaxin-like substances, or the responses to such substances. Our attempts to measure the release of such substances have, so far, failed. On the other hand, the hormone effect in man seems to be most conspicuous when the cause of the experimental inflammation involves a bacterial or contact type of hypersensitivity mechanism. This might be held to suggedt an effect of cortisone on an immunological mechanism concerned in initiating the delayed sort of hypersensitivity response. At present, however, we feel that in man there are insufficient grounds for attributing reduced tuberculin reactivity to such an "anti-allergic" effect of cortisone, though the possibility of such an effect certainly exists. The elucidation of these problems will require studies with less complex processes than inflammation, and will demand a more detailed knowledge of the mechanisms involved in the bacterial type of allergy.
The experiments mentioned were made with Drs. H. C. Goodman, B. Hudson, P. Armitage and Professor G. W. Pickering.
